Review of bleeding events in clinical studies of clopidogrel
10.12092/j.issn.1009-2501.2021.03.015
- Author:
Zhen YUAN
1
;
Bilian CHEN
1
Author Information
1. Department of Geriatrics, Xiangya Hospital, Central South University
- Publication Type:Journal Article
- Keywords:
Bleeding definition;
Bleeding events;
Clopidogrel
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2021;26(3):341-349
- CountryChina
- Language:Chinese
-
Abstract:
P2Y12 receptor antagonist is currently one of the commonly used drugs for the treatment of acute coronary syndromes. Clopidogrel is a representative drug among P2Y12 receptor antagonists. Bleeding events as the most common side effect of this drug have also been concerned. The incidence and risk of bleeding events in large-scale clinical studies of clopidogrel are analyzed and discussed to provide refer-ences for reasonable clinical prescription of clopidogrel.
